cardio-oncology
Advertisement
Many cardio-oncology patients at increased risk for congestive heart failure from cancer therapy have OSA.
City of Hope and COG conducted a clinical trial with the goal of reducing HF risk in childhood cancer survivors.
A cardio-oncology rehabilitation program can benefit cancer survivors at high risk of cardiovascular disease.
Male breast cancer patients are at higher risk of cardiovascular disease, according to a study presented at the American ...
Prolonged androgen deprivation therapy (ADT) was found to impair cardiorespiratory fitness and increase risk of ...
Patients with cancer were less likely to be prescribed cardioprotective medications than cancer-free individuals, a new ...
Patients with cancer have a more than twofold risk of developing atrial fibrillation (AF) compared with the general ...
Cardiac resynchronization therapy (CRT) improved left ventricular ejection fraction (LVEF) after six months in cancer ...
Research published in JACC CardioOncology suggests that neurohormonal therapies are associated with higher left ...
Physical exercise may be a promising and effective treatment for patients with cancer during and after chemotherapy in ...
A new study published in the journal Blood found that cancer patients treated with ibrutinib may have a greater risk for ...
Ibrutinib administration was associated with a number of severe cardiac events, results from a new analysis suggest.
...
The findings of a new study published in JAMA Cardiology suggest that measuring global longitudinal strain (GLS), ...
Medium- and long-term cardiovascular risks are higher among cancer survivors compared to the general population, ...
Many patients with cancer undergoing treatment incur a risk of cardiotoxicity, and these patients are not being made ...
This week’s edition of the Cardio Round-up includes a warning about skipping breakfast, an FDA approval on the ...
A new paper in Cardiovascular Research looks at genomic predisposition to oncology-drug-induced cardiotoxicity, which ...
Patients With Prostate Cancer and CVD at Increased Risk of Death When Prescribed Abiraterone Acetate
A study presented at the American Association for Cancer Research Annual Meeting found that men with advanced prostate ...
New research published in JAMA Oncology suggests that daunorubicin is associated with lower incidence of cardiomyopathy ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.